Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

70.35 -0.13 (-0.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dexcom Inc

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
31 32 Next >
3 Cheap 5G Stocks to Buy Now: May 2024
Investors may want to pay close attention to cheap 5G stocks to buy and hold today. In fact, here are three. 
Via InvestorPlace
$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today
Via Benzinga
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Patience often pays off in the equity markets. 
Via The Motley Fool
NASDAQ:DXCM: a strong growth stock preparing for the next leg up?.
DEXCOM INC (NASDAQ:DXCM), a strong growth stock, setting up for a breakout. 
Via Chartmill
3 Internet of Things (IoT) Stocks with the Potential to Make You an Overnight Millionaire
The market for IoT stocks could be worth about $3.37 trillion by 2031 as the use cases for the technology explodes. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Here's How Much $1000 Invested In DexCom 15 Years Ago Would Be Worth Today
Via Benzinga
Peering Into DexCom's Recent Short Interest
Via Benzinga
Shhh! 3 Secret IoT Stocks Flying Below Wall Street’s Radar
The IoT industry is looking to continue growing strong, if you want high portfolio growth I recommend you buy these top three IoT stocks. 
Via InvestorPlace
Dexcom Stock Continues To Post Very Healthy Profits, Returns
Dexcom earns a lofty No. 5 rank among its peers in the 130-stock Medical-Products industry group. It got a rating upgrade Tuesday. 
Via Investor's Business Daily
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Dexcom Beats First-Quarter Views And Raises Sales Outlook, But Shares Crumble
The company raised the lower bound of its sales guidance for the year. 
Via Investor's Business Daily
$1000 Invested In DexCom 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review
Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser. 
Via Investor's Business Daily
Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why NASDAQ:DXCM Is a Promising High-Growth Stock in the Midst of Consolidation.
Via Chartmill
The Analyst Verdict: DexCom In The Eyes Of 4 Experts
Via Benzinga
Intel Reports Weak Sales, Joins Boyd Gaming, Atlassian And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
DexCom (DXCM) Q1 2024 Earnings Call Transcript
DXCM earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
DXCM Stock Earnings: DexCom Beats EPS, Beats Revenue for Q1 2024
DXCM stock results show that DexCom beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Dexcom Reports First Quarter 2024 Financial Results
From DexCom, Inc.
Via Business Wire
Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating
On Thursday, implantable lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier. 
Via Investor's Business Daily
3 Innovative Stocks to Buy Before Earnings Amid the Market Pullback
Today’s episode of Full Court Finance at Zacks dives into the recent stock market pullback. We then turn our attention to three innovators in their respective industries—Vertiv, Align Technology, and... 
Via Talk Markets
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use. 
Via Investor's Business Daily
3 Weight-Loss ETFs to Profit From the Obesity Drug Boom
Leverage Oprah's shift to prescription weight solutions with Weight-Loss ETFs, targeting companies leading in obesity treatment. 
Via InvestorPlace
Topics ETFs
Disruptive Forces: 3 Game-changing Stocks Reshaping the Tech Landscape
This April, discover three game-changing tech stocks with disruptive technologies poised to future-proof your portfolio in 2024. 
Via InvestorPlace
Why Wall Street Got Even More Excited About The Glucose Monitor — And How Dexcom, Abbott Labs Stand To Benefit
Continuous glucose monitors have spiked in popularity since the advent of weight-loss drugs. Is chronic disease at its end? 
Via Investor's Business Daily
Nasdaq Nightmares: 3 Stocks to Sell Before Reality Sets In
DoorDash, DexCom, and Advanced Micro Devices are three Nasdaq stocks to sell before reality sets in as exuberance may be fading. 
Via InvestorPlace
3 Obesity Drug Stocks Set to Skyrocket as Demand Goes Wild
Discover top obesity drug stocks set to soar as demand surges. Eli Lilly, Novo Nordisk, & Dexcom lead with revolutionary treatments 
Via InvestorPlace
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.